Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ZYME

Zymeworks (ZYME)

Zymeworks Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZYME
DateTimeSourceHeadlineSymbolCompany
03/05/202406:05GlobeNewswire Inc.Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:ZYMEZymeworks Inc
30/04/202420:00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
11/04/202420:00GlobeNewswire Inc.Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:ZYMEZymeworks Inc
08/04/202420:00GlobeNewswire Inc.Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
28/03/202421:00GlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
27/03/202421:00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
08/03/202408:46Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZYMEZymeworks Inc
08/03/202408:36Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ZYMEZymeworks Inc
07/03/202409:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ZYMEZymeworks Inc
07/03/202408:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
07/03/202408:09GlobeNewswire Inc.Zymeworks Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ZYMEZymeworks Inc
06/03/202408:30GlobeNewswire Inc.Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
27/02/202422:00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
23/02/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
14/02/202422:00GlobeNewswire Inc.Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference CallNASDAQ:ZYMEZymeworks Inc
09/02/202408:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
08/02/202422:00GlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
31/01/202422:00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
09/01/202410:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
06/01/202413:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
06/01/202413:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
05/01/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
04/01/202422:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
04/01/202422:15GlobeNewswire Inc.Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025NASDAQ:ZYMEZymeworks Inc
04/01/202422:00GlobeNewswire Inc.Zymeworks Announces Additional Leadership AppointmentsNASDAQ:ZYMEZymeworks Inc
04/01/202408:32Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ZYMEZymeworks Inc
27/12/202300:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
27/12/202300:00GlobeNewswire Inc.Zymeworks Announces $50 Million Private Placement to EcoR1 CapitalNASDAQ:ZYMEZymeworks Inc
16/12/202300:30GlobeNewswire Inc.Zymeworks Added to Nasdaq Biotechnology IndexNASDAQ:ZYMEZymeworks Inc
09/12/202309:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
 Showing the most relevant articles for your search:NASDAQ:ZYME